[Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].

Katsuki Muneoka(Nagara Medical Center), Makoto Miyazaki(Chiba Cancer Center), Masataka Sasaki, Toshifumi Wakai(Niigata University Medical and Dental Hospital), Shinsuke Honma, Jun Sakata, Hiroyuki Wakabayashi, Yoshio Shirai, Junkichi Kanda

PubMed

August 1, 2018

Cited by 2

Related Papers

Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity

|Proceedings of the National Academy of Sciences|2002|1.1k

Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss

|Science|2002|833

The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1

|Journal of Biological Chemistry|2000|453

Hepatic Stearoyl-CoA Desaturase-1 Deficiency Protects Mice from Carbohydrate-Induced Adiposity and Hepatic Steatosis

|Cell Metabolism|2007|433

Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver

|Proceedings of the National Academy of Sciences|2004|404